Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$16.06 - $26.39 $546,040 - $897,260
-34,000 Reduced 69.39%
15,000 $255,000
Q4 2021

Feb 11, 2022

SELL
$41.2 - $73.6 $2.41 Million - $4.31 Million
-58,600 Reduced 54.46%
49,000 $2.23 Million
Q3 2021

Nov 12, 2021

BUY
$59.15 - $91.99 $2.51 Million - $3.91 Million
42,480 Added 65.23%
107,600 $6.82 Million
Q2 2021

Aug 13, 2021

BUY
$63.02 - $95.11 $943,031 - $1.42 Million
14,964 Added 29.83%
65,120 $5.96 Million
Q1 2021

May 14, 2021

BUY
$57.62 - $95.6 $1.3 Million - $2.15 Million
22,500 Added 81.36%
50,156 $3.42 Million
Q4 2020

Feb 05, 2021

SELL
$41.43 - $77.09 $145,005 - $269,815
-3,500 Reduced 11.23%
27,656 $2 Million
Q3 2020

Nov 06, 2020

BUY
$30.88 - $37.94 $190,097 - $233,558
6,156 Added 24.62%
31,156 $1.18 Million
Q2 2020

Aug 13, 2020

BUY
$18.95 - $35.43 $473,750 - $885,750
25,000 New
25,000 $886,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.